SCHEMBL4255284

SCHEMBL4255284

CC(=O)c1cc2c(cc1NCC=Cc1ccc(C(=O)Nc3ccccc3N)cc1)OCO2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.56
ALDH1A1 P00352 4/20 0.53
GAA P10253 1/20 0.53
HPGD P15428 1/20 0.53
KDM4E B2RXH2 3/20 0.48
HDAC2 Q92769 3/20 0.47
POLB P06746 1/20 0.46
TSHR P16473 2/20 0.46
HSD17B10 Q99714 2/20 0.46
USP2 O75604 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HDAC3 O15379 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
PTGS2 P35354 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4255278 1.00 HDAC1 (0.56) HDAC1ALDH1A1GAAHPGDKDM4E
SCHEMBL1066305 0.84 ALDH1A1 (0.58) HDAC1ALDH1A1GAAHPGDKDM4E
SCHEMBL1060538 0.78 HDAC1 (0.60) HDAC1HDAC2
SCHEMBL1060532 0.78 HDAC1 (0.60) HDAC1HDAC2
SCHEMBL211197 0.77 HDAC1 (0.59) HDAC1ALDH1A1GAAHPGDKDM4E
SCHEMBL5163251 0.72 HDAC1 (0.62) HDAC1HDAC2HDAC3NCOR2
SCHEMBL4256762 0.72 HDAC1 (0.82) HDAC1HDAC2HDAC3
SCHEMBL4256767 0.72 HDAC1 (0.82) HDAC1HDAC2HDAC3
SCHEMBL4257193 0.72 HDAC1 (1.00) HDAC1HDAC2HDAC3
SCHEMBL4257198 0.72 HDAC1 (1.00) HDAC1HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023734-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023734-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC6 HDAC1 1/4885ALDH1A1 828/4885GAA 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.